ATE341331T1 - Lipide zur änderung des abwehrsystems - Google Patents
Lipide zur änderung des abwehrsystemsInfo
- Publication number
- ATE341331T1 ATE341331T1 AT01938401T AT01938401T ATE341331T1 AT E341331 T1 ATE341331 T1 AT E341331T1 AT 01938401 T AT01938401 T AT 01938401T AT 01938401 T AT01938401 T AT 01938401T AT E341331 T1 ATE341331 T1 AT E341331T1
- Authority
- AT
- Austria
- Prior art keywords
- lipids
- fatty acids
- glycerol
- acyl
- lipid
- Prior art date
Links
- 150000002632 lipids Chemical class 0.000 title abstract 5
- 230000007123 defense Effects 0.000 title 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 3
- 229930195729 fatty acid Natural products 0.000 abstract 3
- 239000000194 fatty acid Substances 0.000 abstract 3
- 150000004665 fatty acids Chemical class 0.000 abstract 3
- 125000002252 acyl group Chemical group 0.000 abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 abstract 1
- 239000004215 Carbon black (E152) Substances 0.000 abstract 1
- 229930186217 Glycolipid Natural products 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 1
- 150000002314 glycerols Chemical class 0.000 abstract 1
- 229930195733 hydrocarbon Natural products 0.000 abstract 1
- 150000002430 hydrocarbons Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- NJTGANWAUPEOAX-UHFFFAOYSA-N molport-023-220-454 Chemical compound OCC(O)CO.OCC(O)CO NJTGANWAUPEOAX-UHFFFAOYSA-N 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- 150000002482 oligosaccharides Polymers 0.000 abstract 1
- 150000002894 organic compounds Chemical class 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 150000003904 phospholipids Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 150000004043 trisaccharides Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0014437.8A GB0014437D0 (en) | 2000-06-14 | 2000-06-14 | Immune response stimulation |
| GB0026667A GB0026667D0 (en) | 2000-11-01 | 2000-11-01 | Lipids promoting immune response |
| GB0028239A GB0028239D0 (en) | 2000-11-20 | 2000-11-20 | Lipids modulating immune response |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE341331T1 true ATE341331T1 (de) | 2006-10-15 |
Family
ID=27255760
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01938401T ATE341331T1 (de) | 2000-06-14 | 2001-06-13 | Lipide zur änderung des abwehrsystems |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1289530B1 (de) |
| AT (1) | ATE341331T1 (de) |
| AU (1) | AU2001264079A1 (de) |
| DE (1) | DE60123603T2 (de) |
| WO (1) | WO2001095914A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0000891D0 (en) * | 2000-01-14 | 2000-03-08 | Allergy Therapeutics Ltd | Formulation |
| JP5026655B2 (ja) | 2001-04-18 | 2012-09-12 | プロメティック、バイオサイエンシーズ、インコーポレーテッド | 好中球の生存及び活性化因子としての中鎖脂肪酸、グリセリド及び類似体 |
| ATE419846T1 (de) | 2003-02-07 | 2009-01-15 | Prometic Biosciences Inc | Fettsäuren mittlerer kettenlänge, glyceride und analoga als stimulatoren der erythropoiese |
| AU2016256979B2 (en) | 2015-05-04 | 2021-01-28 | Genfit | Method for preparing transmembrane pH-gradient vesicles |
| MX2018015188A (es) | 2016-06-08 | 2019-08-21 | Sunregen Healthcare Ag | Lipidos con un numero impar de atomos de carbono y su uso como una composicion farmaceutica o como un suplemento nutricional. |
| BR112020004023A2 (pt) * | 2017-09-12 | 2020-09-08 | Sunregen Healthcare Ag | uso de um composto e composição farmacêutica ou suplemento nutricional |
| GB201718741D0 (en) | 2017-11-13 | 2017-12-27 | Davies Professor Tony | Constructs comprising fatty acids |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57145810A (en) * | 1982-02-01 | 1982-09-09 | Toyama Chem Co Ltd | Immunological activator containing lysophospholipid and preparation thereof |
| US4978654A (en) * | 1984-04-16 | 1990-12-18 | Board Of Regents, The University Of Texas System | Composition and method for treatment of disseminated fungal infections in mammals |
| SE9101642D0 (sv) * | 1991-05-30 | 1991-05-30 | Kabi Pharmacia Ab | Phospholipids |
| IL121322A (en) * | 1997-07-16 | 2002-07-25 | Modus Biolog Membranes Ltd | Modular pharmacological preparation of the immune system based on fats and its preparation |
| GB9930862D0 (en) * | 1999-12-29 | 2000-02-16 | Porter William L | Immune response stimulation |
-
2001
- 2001-06-13 AU AU2001264079A patent/AU2001264079A1/en not_active Abandoned
- 2001-06-13 EP EP01938401A patent/EP1289530B1/de not_active Expired - Lifetime
- 2001-06-13 WO PCT/GB2001/002568 patent/WO2001095914A1/en not_active Ceased
- 2001-06-13 DE DE60123603T patent/DE60123603T2/de not_active Expired - Lifetime
- 2001-06-13 AT AT01938401T patent/ATE341331T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1289530A1 (de) | 2003-03-12 |
| AU2001264079A1 (en) | 2001-12-24 |
| DE60123603D1 (de) | 2006-11-16 |
| EP1289530B1 (de) | 2006-10-04 |
| DE60123603T2 (de) | 2007-08-16 |
| WO2001095914A1 (en) | 2001-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9807443A (pt) | Processos para reduzir a incidência de enterocolite necrótica em uma criança e para a produção de uma fórmula enteral, e, fórmulas enteral aperfeiçoada contendo ácido araquidÈnico e ácido docosaexaenóico e adequada para alimentar crianças. | |
| BR9205526A (pt) | Misturas de oleos microbianos e usos dos mesmos | |
| KR960017617A (ko) | 수중유 유제의 안정화제로 사용되는 살리실산 유도체 | |
| BR0312158A (pt) | Sequências de ácido nucléico e métodos de uso para a produção de plantas com ácidos graxos poliinsaturados modificados | |
| MX9100229A (es) | Composiciones alimenticias y farmaceuticas que contienen acidos grasos monoinsaturados de cadena corta,y metodos de uso | |
| ES2069244T3 (es) | Composicion cosmetica, farmaceutica o alimentaria que comprende vesiculas lipidicas. | |
| ES2036922B1 (es) | Procedimiento de obtencion de mezclas de polisacaridos de bajos pesos moleculares. | |
| BR0009340B1 (pt) | composiÇço adequada para uso na pele ou no cabelo, produto para aplicaÇço na pele ou no cabelo, mÉtodo para preparar uma composiÇço adequada para aplicaÇço na pele ou no cabelo, e, uso de uma composiÇço. | |
| ATE341331T1 (de) | Lipide zur änderung des abwehrsystems | |
| MY107327A (en) | Aqueous cosmetic composition and preparation method thereof. | |
| KR20180120147A (ko) | 특정한 당지질을 함유하는 동물 사료 | |
| NZ220818A (en) | Skin tanning compositions containing an oil fraction, an emulsifying system, and a panthenol derivative | |
| BR0211771A (pt) | Misturas de lìpìdeo e produtos alimentìcios contendo ácido graxo oléico e ácidos graxos Èmega-6, designados para aumentar o nìvel de lipìdeo intramiocelular | |
| NZ333226A (en) | Immunstimulating lipid formulation | |
| TR199801784T2 (en) | Kuma� yumu�atma bile�i�i / bile�imi. | |
| ATE138531T1 (de) | Triglyceride-zusammensetzungen gegen fettbleichen | |
| DE502004010652D1 (de) | Neuartige fettpulver | |
| BG102234A (en) | Esters of iodized fatty acids, the iodized fatty acids and their derivatives produced by the the addition of hydrogen iodide in the application of alkylylated derivatives and alkaline iodides, and their pharmacological application | |
| RU2135555C1 (ru) | Пищевой антиоксидант | |
| KR970014571A (ko) | 1,2-디브로모-2,4-디시아노부탄과 파라하이드록시벤조산 에스테르와의 상승작용성 항미생물성 조성물 | |
| AU2003240189A1 (en) | Long chain unsaturated oxygenated compounds and their use in the therapeutical, cosmetic and nutraceutical field | |
| WO2003056928A1 (fr) | Compositions de graisse et d'huile permettant de reduire les lipides sanguins | |
| ATE310527T1 (de) | Lipide zur stimulierung der immunreaktion | |
| Aissa et al. | Monolayer properties of synthesized tyrosyl esters | |
| Bansal et al. | Phospholipid and fatty acid composition of Microsporum cookei: Effect of exogenous unsaturated fatty acids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |